Efanesoctocog alfa Uses, Dosage, Side Effects and more
Efanesoctocog alfa is under investigation in clinical trial NCT04759131 (Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A).
Trade Name | Efanesoctocog alfa |
Generic | Efanesoctocog alfa |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |